Details

Industry: Industrial Markets, Pharmaceuticals, Infrastructure, Government and Healthcare, Healthcare
Type: Business and industry issue
Date: 6/10/2011

China's pharmaceutical industry – Poised for the giant leap

This report outlines the developments taking place in China's pharmaceutical sector and how these may affect both multinationals and local industry players over the coming five years.

Download Now

China's pharmaceutical industry – Poised for the giant leap (PDF 2.59MB)

PDF files require Adobe Reader to view

Download Adobe Reader

Sign up now

Subscribe to receive email alerts or e-Newsletters from KPMG China when new updates are available.

Update profile and manage subscription

Not a member? Register

China in focus

Sector Studies - These studies feature the industry insights and latest developments of specific sectors in China.

Latest articles & publications

	Going Social

	China's 12th Five-Year Plan: Healthcare sector

	Agenda Issue 06 - Oct/Nov 2010



	More articles and publications

© 2012 KPMG Advisory (China) Limited, a wholly foreign owned enterprise in China and KPMG Huazhen, a Sino-foreign joint venture in China, are member firms of the KPMG network of independent member firms affiliated with KPMG International Cooperative ("KPMG International"), a Swiss entity. All rights reserved.

© 2012 KPMG, a Hong Kong partnership and a member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative ("KPMG International"), a Swiss entity. All rights reserved.

KPMG and the KPMG logo are registered trademarks of KPMG International Cooperative ("KPMG International"), a Swiss entity.

KPMG International Cooperative (“KPMG International”) is a Swiss entity. Member firms of the KPMG network of independent firms are affiliated with KPMG International. KPMG International provides no client services. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm.